Comprehensive Study Guide on Bluetongue Virus and Related Orbiviruses

Tissue Tropisms within Reoviridae and Related Genera

• Mammalian Reoviruses: Exhibit specific tissue affinity for the epithelial linings of the respiratory tract and the intestinal tract.

• Avian Reoviruses: Exhibit preferential tropism for synovial membranes and tendons, where viral multiplication takes place.

• Orbiviruses (General Vector Tropism): Possess targeted affinity for the salivary tract and salivary glands of their arthropod insect vectors.

• Bluetongue Virus (BTV) and African Horse Sickness Virus (AHSV): Characterized as pantropic viruses possessing broad tissue affinity, targeting:

  • Vascular endothelium of small blood vessels

  • Epithelial cells of the buccal cavity

  • Intestinal epithelial cells

  • Myocardial cells of the heart

• Rotaviruses: Exhibit strict tropism for mature enterocytes of the intestinal villi, multiplying within intestinal cells.

Overview, History, and Geographic Distribution of Bluetongue

• Nomenclature and Synonyms: Bluetongue is also recognized in veterinary literature under several historical and clinical synonyms:

  • Sore muzzle

  • Muzzle disease

  • Ovine catarrhal fever

  • Pseudo foot and mouth disease

• General Definition: An infectious, non-contagious, arthropod-borne viral disease that primarily impacts domestic and wild ruminants, with domestic sheep exhibiting the highest susceptibility and clinical severity.

• Historical Discovery and Global Spread:

  • Initially identified, recognized, and described in South Africa.

  • For several decades following its initial identification, the geographical range of the disease was believed to be restricted exclusively to the African continent.

  • Over the past $40\,\text{years}$, both clinical outbreaks and serological evidence of viral circulation have emerged across numerous temperate and tropical countries worldwide.

• Epidemiological Emergence in India: Bluetongue infection was first officially documented and reported in India from the state of Maharashtra in $1964$.

Etiology and Serotype Diversity

• Taxonomic Classification: Bluetongue virus (BTV) is the prototype species belonging to the genus Orbivirus, classified within the family Reoviridae.

• Known Serotypes Globally: At least $28$ distinct serotypes of BTV have been characterized globally to date:

  • BTV-27: Identified and isolated from Corsica, France, in $2014$.

  • BTV-28: Isolated in Israel in $2020$ from contaminated live-attenuated sheep pox and lumpy skin disease vaccines.

• Serotype Prevalence in India: A total of $23$ distinct serotypes have been documented in India based on the identification of specific neutralizing antibodies and direct viral isolations (specifically, all recognized serotypes except serotypes $22$, $25$, $26$, $27$, and $28$).

Virion Architecture and Structural Composition

• Morphological Characteristics:

  • Virions are non-enveloped, spherical particles.

  • The intact virion exhibits an outer diameter of approximately $69\,\text{nm}$.

  • Possesses a two-layered (double-layered) protein capsid arranged in icosahedral symmetry.

• Outer Capsid Layer:

  • Formed by a diffuse outer protein shell composed of two major structural proteins: VP2 and VP5.

  • VP2: Serves as the primary neutralizing antigen of the virus and is the decisive structural determinant of serotype specificity.

  • VP5: Cooperates with VP2 in cellular attachment and membrane penetration.

  • The outer capsid layer dissociates relatively easily from the underlying core particle.

• Inner Core Particle:

  • Structurally anchored to the outer capsid proteins; both VP2 and VP5 are directly attached to the underlying core-surface protein VP7.

  • Core Surface: Composed of $260$ trimers of the VP7 protein organized into ring-like structural formations. VP7 functions as the primary determinant of serogroup specificity.

  • Subcore Shell: Situated beneath the VP7 layer, composed of $120$ copies of the VP3 structural protein.

  • Transcriptase Complex and Genome Interior: The VP3 shell encloses the viral enzymatic transcriptase complex (comprising three minor enzymatic proteins: VP1, VP4, and VP6) and the viral genomic material.

• Viral Genome Organization:

  • Composed of $10$ segments of double-stranded RNA (dsRNA).

  • The viral genomic RNA segments carry a methylated $5'$ cap structure but lack a polyadenylated ($\text{poly(A)}$) $3'$ tail.

  • The $10$ segments encode a total of $11$ identified proteins:

  • Seven structural proteins: VP1, VP2, VP3, VP4, VP5, VP6, and VP7.

  • Four nonstructural proteins: NS1, NS2, NS3, and NS4.

Physical and Chemical Stability

• Protein-Mediated Stability: BTV exhibits marked stability in protein-rich environments. The virus can retain infectivity and be successfully re-isolated from whole blood stored at room temperature for multiple years.

• Solvent Sensitivity: Possesses sensitivity to ether and standard lipid solvents despite being a non-enveloped virion.

• pH Tolerance and Acid Lability:

  • Demonstrates stability across a physiological pH range of $\text{pH } 5.6\text{ to } 8.0$.

  • Highly sensitive to acid conditions; viral infectivity is rapidly abolished at acidic values of $\text{pH } \le 6.0$.

• Chemical Inactivation: Viral infectivity is completely inactivated by exposure to:

  • Phenols

  • Formalin

  • Ethanol at a concentration of $95\%$

  • $\beta$-propiolactone

• Hemagglutination: BTV possesses the intrinsic biological property to agglutinate mammalian red blood cells (RBCs).

Viral Replication Cycle

• Intracellular Site: Viral entry, transcription, translation, and assembly processes take place entirely within the cytoplasm of host cells.

• Attachment and Penetration:

  • Cellular internalisation proceeds via clathrin-dependent, receptor-mediated endocytosis.

  • Surface membrane glycoproteins on host cells function as attachment receptors.

  • The outer capsid proteins (VP2 and VP5) along with the core protein VP7 actively mediate receptor engagement and subsequent endosomal membrane penetration.

• Uncoating and Enzymatic Activation:

  • Following endosomal uptake, removal of the outer capsid shell (VP2 and VP5) occurs.

  • Partial uncoating yields an active core particle, which directly derepresses and activates the core-associated RNA-dependent RNA polymerase (transcriptase, VP1) and the RNA capping enzyme (VP4).

  • If complete uncoating of the inner core particle occurs, BTV infectivity is destroyed.

• Virion Assembly and Release:

  • Newly assembled progeny virions can bud through the plasma membrane in a controlled process mediated by the nonstructural protein NS3 prior to the eventual terminal lysis of the host cell.

  • Final, large-scale viral dissemination coincides with complete host cell lysis.

Host Susceptibility and Affected Species

• Highly Susceptible Domestic Hosts: Domestic sheep of all ages exhibit high susceptibility to infection, demonstrating the most severe clinical manifestations and highest mortality rates.

  • Young sheep and individuals of the Merino breed are exceptionally vulnerable to severe disease.

• Mild or Subclinical Ruminant Hosts:

  • Cattle, domestic goats, and wild ruminants typically experience mild, subclinical, or inapparent infections.

  • These species function as vital maintenance hosts and non-clinical carriers, supporting prolonged virus circulation.

• Camelids: Susceptible to BTV infection, exhibiting varying clinical responses.

• Refractory and Non-Susceptible Species: Under natural epidemiological conditions, horses, dogs, cats, ferrets, laboratory rabbits, and guinea pigs are entirely non-susceptible to infection.

• Iatrogenic Transmission in Canines: A specific clinical exception has been documented in domestic dogs, wherein severe clinical disease and high mortality occurred in pregnant bitches that received a commercial canine vaccine inadvertently contaminated with live Bluetongue virus.

Transmission Dynamics and Vector Biology

• Primary Biological Vectors: BTV is transmitted primarily by biting midges belonging to the genus Culicoides (commonly termed midges or "no-see-ums").

• Enzootic Vector Cycle:

  • Transmission functions predominantly through an ongoing silent cycle between Culicoides midges and cattle.

  • Once the viral load and infected vector density reach an elevated threshold within the bovine reservoir, the virus spills over into surrounding, highly susceptible sheep populations.

  • This spillover event characteristically occurs in late summer or autumn.

• Kinetics within the Vector:

  • Midges acquire the pathogen while blood-feeding on an infected, viremic host animal.

  • BTV replicates systemically within the insect tissues, disseminating to the salivary glands where it reaches maximum infectious titers within $6\text{--}8\,\text{days}$ post-ingestion.

  • Once infected, a midge remains infective and capable of vectoring the virus for the remainder of its biological life.

• Seasonal Dynamics: Vector-mediated transmission peaks sharply during mid-summer and the rainy season, correlating directly with the surge in Culicoides population density.

• Non-Vector Transmission Modes:

  • Venereal/Germline: Excretion in semen and colonization of embryos.

  • Transplacental (Vertical): Transmission across the placenta from an infected dam to the developing fetus.

  • Oral Ingestion: Neonatal ruminants can contract infection by ingesting virus-contaminated colostrum.

  • Mechanical Transmission: Iatrogenic dissemination via contaminated hypodermic needles or surgical instruments carrying infected blood.

Pathogenesis and Pathophysiology

• Initial Replication and Dissemination:

  • Inoculation by a feeding midge introduces the virus into the dermis, followed by primary replication within draining regional lymph nodes.

  • The virus enters the efferent lymph and systemic circulation, seeding primary target organs including the lungs, spleen, and distant lymph nodes.

• Cellular Associations in Viremia:

  • Progeny virions are released into the bloodstream where they associate with all circulating blood cell lineages.

  • Virions show preferential association with blood platelets and red blood cells (erythrocytes).

  • Stable sequestering within invaginations of erythrocyte membranes shields the virus from circulating neutralizing antibodies, prolonging viremia for $35\text{--}60\,\text{days}$ post-infection and maximizing the probability of uptake by hematophagous Culicoides vectors.

• Vascular Endothelial Injury:

  • Virulent viral strains localize and replicate extensively within the endothelial cells lining capillaries and small blood vessels.

  • Endothelial replication induces cellular necrosis, vascular thrombosis, blood stasis, vascular leakage, inflammatory exudation, and localized tissue hypoxia.

• Secondary Lesion Mechanics:

  • Epithelial surface erosions and ulcerative lesions manifest in hypoxic anatomical zones, frequently triggered or exacerbated by mechanical friction or minor physical trauma.

  • Hypoxic, damaged mucosal margins are prone to secondary opportunistic bacterial invasion.

  • Severe fluid exudation induces widespread systemic edema, with acute pulmonary edema representing the most prominent pathological consequence.

Clinical Manifestations and Syndromes

• Incubation Period: In sheep, clinical signs characteristically appear within an incubation timeframe of $7\text{--}10\,\text{days}$.

• Bimodal Clinical Presentation: The disease in sheep manifests under two principal syndromes: the vascular affection syndrome and the reproductive syndrome.

• Vascular Affection Syndrome:

  • Pyrexia: Acute onset of high fever reaching up to $41.6^\circ\text{C}$.

  • Oral and Nasal Mucosa: Severe hyperemia of the buccal mucous membranes, copious salivation, and oral frothing. Nasal discharge begins as serous fluid, rapidly transitioning to thick mucopurulent exudate that dries to form prominent crusts occluding the nostrils.

  • Oral Cavity Pathology: Intense hyperemia, petechial hemorrhages, and marked edematous swelling involving the buccal mucosa, dental pads, and tongue.

  • Cyanosis ("Bluetongue"): In severe, advanced vascular compromise, local hypoxia and venous stasis cause the tongue to turn cyanotic and purplish-blue, providing the classical name of the condition.

  • Pododermatitis and Lameness: Hyperemia and severe pain localized to the coronary bands of the hooves; affected sheep become recumbent and show extreme reluctance to stand or move.

  • Anorexia: Painful mucosal erosion and ulceration of the oral cavity prevent mastication, rendering sheep reluctant to eat.

  • Head and Cervical Edema: Pronounced subcutaneous edema infiltrates the head, submandibular space, and neck, resulting in a classical "monkey-face appearance".

  • Dermatologic and Fleece Sequelae: Hyperemia of the skin in convalescing animals causes follicular disruption, culminating in a bilateral loss or shedding of the fleece termed "wool break".

  • Myopathy: Severe degeneration of skeletal muscle bundles occurs, resulting in torticollis ("wry neck").

  • Convalescence and Mortality: Recovery is protracted and extended over months. Flock morbidity can reach $100\%$, while mortality rates vary widely between $0\%$ and $50\%$. Terminal cases die from acute respiratory distress caused by severe pulmonary edema, often complicated by acute secondary bacterial bronchopneumonia.

• Reproductive Syndrome:

  • Infection of pregnant ewes can cause embryonic resorption, abortion, stillbirth, or the birth of weak, non-viable offspring showing severe cerebral malformations, termed "dummy lambs".

  • Severe abortion storms during early gestation can result in the catastrophic loss of an entire seasonal lamb crop.

Pathological Lesions and Post-Mortem Findings

• External and Cranial Lesions:

  • Extensive subcutaneous edema of the facial structures and ears.

  • Desiccated, crusty mucopurulent exudate obstructing the external nares.

• Alimentary Tract Alterations:

  • Multifocal to extensive mucosal ulcerations and petechial-to-ecchymotic hemorrhages throughout the oral cavity, esophagus, and forestomachs (rumen, reticulum, and omasum).

  • Hemorrhagic enteritis and mucosal petechiation extending along the intestinal tract.

• Cardiorespiratory Lesions:

  • Pulmonary Architecture: Massive alveolar and interstitial pulmonary edema; the lumen of the trachea and the entire bronchial tree are filled with frothy, proteinaceous transudate.

  • Hydrothorax: Accumulation of up to $2\,\text{litres}$ of straw-colored, plasma-like serous transudate within the pleural cavity. Pulmonary edema and extensive hydrothorax are the primary immediate causes of acute mortality in sheep.

  • Pulmonary Artery Hemorrhage: Distinctive, pathognomonic focal hemorrhages localized strictly within the tunica media near the anatomical base of the pulmonary artery.

• Myocardial and Skeletal Muscle Necrosis:

  • Multifocal, pale areas of degenerative necrosis within the myocardium, prominently localized in the wall of the left ventricle.

  • Widespread patchy degeneration and necrosis running through the skeletal muscle systems of the neck, limbs, and abdominal wall.

Diagnostic Procedures and Laboratory Identification

• Field and Presumptive Diagnosis:

  • Established by correlating clinical signs, post-mortem vascular lesions, and seasonal occurrence during temperate late summer/autumn periods.

  • Supported by epidemiological coincidence with high local biting midge activity and flock histories of acute physical wasting accompanied by severe pododermatitis (foot rot).

• Collection, Storage, and Transport of Diagnostic Specimens:

  • Live Animals: The preferred diagnostic specimen is whole blood collected in anticoagulants during the early febrile phase. Erythrocytes must be washed and resuspended in sterile phosphate-buffered saline (PBS) or isotonic $0.9\%$ sodium chloride ($\text{NaCl}$) solution.

  • Specimen Storage Conditions: Washed blood samples must be held at $4^\circ\text{C}$. Samples intended for viral isolation must never be frozen, as ice crystallization lyses cell membranes and dramatically reduces viral recovery.

  • Unrefrigerated Field Transport: If cold-chain infrastructure is unavailable, whole blood samples may be drawn directly into oxalate-phenol-glycerin (OPG) preservative solution.

  • Post-Mortem Tissues: Spleen, liver, red bone marrow, brain tissue, and prescapular/mesenteric lymph nodes collected immediately after death. Tissue samples must be refrigerated at $4^\circ\text{C}$ and transported on wet ice.

  • Prohibition of Dry Ice: Tissue and blood specimens must never be transported on dry ice; gaseous carbon dioxide ($\text{CO}_2$) sublimates into the container, lowering the specimen environment to $\text{pH } \le 6.0$, which inactivates the virus.

• Virus Isolation Methodologies:

  • Embryonated Chicken Eggs:

  • Growth can be accomplished in $6\text{-day-old}$ embryonated eggs via the yolk sac route.

  • Washed erythrocyte pellets disrupted in sterile distilled water or lysed via sonication can be inoculated intravenously (IV) into $10\text{--}11\text{-day-old}$ chicken embryos. The intravenous route is $100\,\text{times}$ more sensitive for isolating BTV than the yolk sac route.

  • Viral propagation can also be achieved across the chorioallantoic membrane (CAM), producing embryo mortality within $4\text{--}8\,\text{days}$.

  • Serial passage of wild-type virulent strains in embryonated eggs at sub-physiological incubation temperatures below $37.5^\circ\text{C}$ achieves viral attenuation without loss of protective antigenicity.

  • Diagnostic embryo mortality is characterized by severe cutaneous hemorrhages that turn the embryo a pathognomonic "cherry red" color.

  • Laboratory Animal Inoculation:

  • Transmission testing can be confirmed by inoculating susceptible sheep.

  • BTV adapts to propagate in the brain tissue of unweaned suckling mice and hamsters following intracerebral injection, resulting in acute encephalitis and death within $3\text{--}7\,\text{days}$.

  • Cell Culture Systems:

  • Isolation is achieved using continuous mammalian cell lines such as BHK-21, Vero, or the L929 cell line.

  • Propagation can also occur in continuous mosquito cell lines, notably AA (Aedes albopictus) cells, generally through successive blind passages.

  • Primary cell systems derived from bovine tissues support growth, including primary calf kidney, calf adrenal, and calf testicular cell cultures.

  • Cytopathic effect (CPE) manifests within $24\text{--}72\,\text{hours}$ post-infection, characterized by discrete focal patches of enlarged, rounded, and refractile degenerating cells.

  • Confirmation of CPE requires immunological identification via the Immunofluorescence Technique (IFT), Immunoperoxidase Technique (IPT), or Virus Neutralization Test (VNT).

• Immunological and Serological Assays:

  • Serogroup-Specific Identification (Targeting VP7):

  • Agar Gel Immunodiffusion (AGID)

  • Complement Fixation Test (CFT)

  • Dot-ELISA

  • Competitive ELISA (c-ELISA)

  • Serotype-Specific Identification (Neutralization Assays):

  • Carried out in BHK-21, Vero, or L929 cell cultures using one of four specific neutralisation assays:

    1. Plaque reduction test

    2. Plaque inhibition test

    3. Fluorescent neutralization test

    4. Microtitre neutralization test

• Molecular Diagnostic Assays:

  • Conventional Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) and real-time quantitative PCR (qPCR) provide rapid identification of viral RNA and can achieve direct molecular serotyping.

• Official Tests for International Animal Movement:

  • Polymerase Chain Reaction (PCR)

  • Competitive Enzyme-Linked Immunosorbent Assay (c-ELISA)

  • Agar Gel Immunodiffusion (AGID)

Differential Diagnosis

• Primary Pathological Look-Alikes: Bluetongue exhibits clinical and pathological signs that overlap with several major livestock diseases, requiring differential diagnostic exclusion:

  • Foot-and-Mouth Disease (FMD): Differentiated by characteristic vesicle formation, rupture, and rapid contagious spread affecting multiple cloven-hoofed species.

  • Peste des Petits Ruminants (PPR): Differentiated by severe necrotizing stomatitis accompanied by profuse, intractable diarrhea and necrotizing enteritis.

  • Contagious Ecthyma (Orf): Differentiated by proliferative, verrucose, scabby pustular encrustations restricted predominantly to the mucocutaneous junctions of the lips.

  • Photosensitization: Differentiated by severe solar dermatitis, necrosis, and superficial sloughing restricted exclusively to non-pigmented, white areas of skin exposed to sunlight.

  • Bovine/Ovine Pneumonia: Differentiated by primary pulmonary consolidation lacking coronary band hyperemia or oral mucosal ulcerations.

  • Foot Rot (Pododermatitis) and Foot Abscesses: Characterized by localized interdigital necrotizing bacterial infections that lack systemic viremic manifestations, fever, or oral erosions.

Immunological Protection and Vaccination Strategies

• Nature of Protective Immunity:

  • Natural infection with a single BTV serotype stimulates long-lasting, solid protective immunity directed specifically against reinfection with that exact homologous serotype.

  • Cross-protection against heterologous serotypes is negligible or absent; immunity depends strictly on circulating serotype-specific virus-neutralizing antibodies directed against the VP2 capsid protein.

  • Effective prophylactic immunization in endemic environments requires multivalent formulations matching all circulating field serotypes.

• Vector Abatement Measures: Environmental control strategies require lowering vector burdens via the topical application of insect repellents, whole-animal insecticides, and larvicidal treatments targeted at Culicoides breeding sites.

• Live-Attenuated Vaccines (LAV):

  • Advantages: Elicit strong, durable, serotype-specific immunity following a single injection and prevent clinical disease.

  • Contraindications and Risks:

  • LAV strains propagated in embryonated eggs induce fetal death, severe embryonic loss, and congenital hydranencephaly or porencephaly in sheep.

  • Strictly contraindicated for administration to pregnant ewes.

  • Under-attenuated vaccine seed stocks can trigger clinical bluetongue signs in inoculated animals.

  • Vaccinal virus strains achieve sufficient viremia to be taken up by feeding Culicoides vectors, risking viral transmission and genetic reassortment with circulating wild-type strains.

• Inactivated (Killed) Vaccines:

  • Inactivated products are safe, completely eliminating risks of iatrogenic abortion, teratogenesis, or wild-type genomic reassortment.

  • Limitations: Commercial availability is restricted to a small number of serotypes, and products require an initial two-dose primary course followed by regular booster injections.

  • Vaccination Timing: Flocks must be vaccinated annually, scheduled several weeks prior to the onset of the breeding season and ahead of the seasonal emergence of Culicoides during the rains.

• Recombinant Vaccines: Modern subunit and virus-like particle (VLP) recombinant constructs have been developed experimentally to confer protective immunity without reversion risks, though they remain unavailable commercially.

• The TANUVAS Inactivated Pentavalent Vaccine (India):

  • Developed by the Tamil Nadu Veterinary and Animal Sciences University (TANUVAS).

  • Formulation: Pentavalent inactivated vaccine containing five regionally prevalent Indian serotypes: BTV-1, BTV-2, BTV-10, BTV-16, and BTV-23.

  • Production: Viral serotypes are propagated and adapted in BHK-21 cell cultures, inactivated via the combined application of Binary ethyleneimine (BEI) and formalin, and formulated with a Montanide oil adjuvant.

  • Target Host and Safety: Safe for administration to young lambs starting at $3\,\text{months}$ of age and completely safe for use in pregnant ewes.

  • Dosing and Timing: Administered as a $2\,\text{ml}$ dose via subcutaneous injection.

  • Epidemiological Scheduling: Flocks are vaccinated annually between July and September, establishing protective immunity prior to the onset of the Northeast monsoon (which spans October through January), during which vector densities surge and peak outbreak transmission occurs.

Tissue Tropisms within Reoviridae and Related Genera

• Mammalian Reoviruses: Epithelial linings of the respiratory and intestinal tracts.

• Avian Reoviruses: Synovial membranes and tendons.

• Orbiviruses (General Vector Tropism): Salivary glands and salivary tracts of insect vectors.

• Bluetongue Virus (BTV) and African Horse Sickness Virus (AHSV): Pantropic affinity, targeting vascular endothelium, buccal epithelium, intestinal cells, and myocardium.

• Rotaviruses: Mature enterocytes of intestinal villi.

Overview, History, and Geographic Distribution of Bluetongue

• Synonyms: Sore muzzle, Muzzle disease, Ovine catarrhal fever, Pseudo foot and mouth disease.

• Definition: Infectious, non-contagious, arthropod-borne viral disease of ruminants; domestic sheep show highest susceptibility and clinical severity.

• Distribution & Emergence: Initially identified in South Africa; now globally distributed. First documented in India from Maharashtra in $1964$.

Etiology and Serotype Diversity

• Classification: Prototype Orbivirus within the family Reoviridae.

• Global Serotypes: At least $28$ recognized serotypes (including BTV-27 from Corsica and BTV-28 isolated from contaminated vaccine in Israel).

• Indian Serotypes: $23$ documented serotypes (all except serotypes $22$, $25$, $26$, $27$, and $28$).

Virion Architecture and Structural Composition

• Morphology: Non-enveloped, $69\,\text{nm}$ diameter, double-layered icosahedral capsid.

• Outer Capsid: Composed of VP2 (primary neutralizing antigen and determinant of serotype specificity) and VP5 (membrane penetration).

• Inner Core Particle:

  • VP7: Outer surface of core ($260$ trimers); primary determinant of serogroup specificity.

  • VP3: Subcore shell ($120$ copies) enclosing the transcriptase complex (VP1, VP4, VP6).

• Genome: $10$ segments of dsRNA with a methylated $5'$ cap and no $\text{poly(A)}$ tail; encodes $7$ structural (VP1–VP7) and $4$ nonstructural proteins (NS1–NS4).

Physical and Chemical Stability

• Stability: Highly stable in protein-rich media; survives in blood at room temperature for years.

• Lability: Acid-sensitive (inactivated rapidly at $\text{pH } \le 6.0$); sensitive to ether and lipid solvents.

• Inactivation: Inactivated by formalin, phenols, $95\%$ ethanol, and $\beta$-propiolactone.

• Hemagglutination: Intrinsic ability to agglutinate mammalian RBCs.

Viral Replication Cycle

• Internalization: Clathrin-dependent, receptor-mediated endocytosis into host cell cytoplasm.

• Uncoating: Removal of outer capsid (VP2/VP5) activates core transcriptase (VP1) and capping enzyme (VP4); complete uncoating abolishes infectivity.

• Progeny Release: Virions bud through the plasma membrane via NS3 prior to terminal host cell lysis.

Host Susceptibility and Affected Species

• High Susceptibility: Domestic sheep (especially young animals and Merino breed) suffer severe disease and high mortality.

• Maintenance Reservoirs: Cattle, goats, and wild ruminants typically develop subclinical or mild infections, acting as primary viral reservoirs.

• Vaccine Accidental Inoculation: Severe disease and mortality documented in pregnant bitches vaccinated with BTV-contaminated canine vaccines.

Transmission Dynamics and Vector Biology

• Primary Biological Vector: Biting midges (Culicoides spp.); replicate systemically and reach peak salivary titers within $6\text{--}8\,\text{days}$, remaining infective for life.

• Transmission Cycle: Silent vector-cattle maintenance cycle with late summer/autumn spillover to sheep.

• Non-Vector Routes: Transplacental (vertical), venereal (semen), colostral ingestion in neonates, and contaminated hypodermic needles.

Pathogenesis and Pathophysiology

• Viremia: Extended viremia ($35\text{--}60\,\text{days}$) enabled by viral sequestering within erythrocyte membrane invaginations, evading neutralizing antibodies.

• Endothelial Necrosis: Viral replication in capillary endothelial cells induces vascular thrombosis, blood stasis, localized tissue hypoxia, and widespread edema (especially pulmonary edema).

Clinical Manifestations and Syndromes

• Incubation Period: $7\text{--}10\,\text{days}$.

• Vascular Syndrome:

  • High pyrexia (up to $41.6^\circ\text{C}$), hyperemic oral mucosa, copious salivation, and crusted mucopurulent nasal discharge.

  • Cyanotic, purplish-blue tongue ("bluetongue") resulting from severe hypoxia and venous stasis.

  • Hyperemia and pain at coronary bands causing lameness and recumbency.

  • Pronounced head and neck edema ("monkey-face appearance"), bilateral fleece shedding ("wool break"), and torticollis ("wry neck").

• Reproductive Syndrome: Embryonic resorption, abortions, stillbirths, and hydranencephalic "dummy lambs".

• Mortality: Flocks exhibit up to $100\%$ morbidity and $0\text{--}50\%$ mortality, primarily due to acute pulmonary edema.

Pathological Lesions and Post-Mortem Findings

• Cardiorespiratory: Pathognomonic focal hemorrhage in the tunica media at the base of the pulmonary artery; extensive hydrothorax (up to $2\,\text{litres}$) and frothy pulmonary edema.

• Musculature: Degenerative necrosis in the left ventricular myocardium and skeletal muscle groups.

• Alimentary: Extensive mucosal petechiation and ulceration throughout the oral cavity, esophagus, and forestomachs.

Diagnostic Procedures and Laboratory Identification

• Sample Handling: Washed erythrocytes in PBS stored at $4^\circ\text{C}$; do not freeze and never transport on dry ice ($\text{CO}_2$ lowers specimen $\text{pH } \le 6.0$, inactivating the virus).

• Egg Inoculation: Intravenous inoculation of $10\text{--}11\text{-day-old}$ embryonated chicken eggs ($100\,\text{times}$ more sensitive than yolk sac route); embryo death manifests with pathognomonic "cherry red" cutaneous hemorrhage.

• Cell Culture: Isolation in BHK-21 or Vero cells producing cytopathic effects within $24\text{--}72\,\text{hours}$.

• Identification Tests: AGID, CFT, and c-ELISA for group-specific VP7 detection; virus neutralization assays for serotyping; PCR and c-ELISA for international movement.

Differential Diagnosis

• Foot-and-Mouth Disease (FMD): Differentiated by characteristic vesicular lesions.

• Peste des Petits Ruminants (PPR): Differentiated by severe necrotizing diarrhea and enteritis.

• Contagious Ecthyma (Orf): Differentiated by proliferative, encrusted labial scabs.

• Photosensitization: Lesions strictly limited to non-pigmented white skin.

• Foot Rot: Exclusively localized interdigital bacterial infection lacking systemic viremia.

Immunological Protection and Vaccination Strategies

• Protective Immunity: Long-lasting but strictly serotype-specific; mediated by neutralizing antibodies against VP2.

• Live-Attenuated Vaccines: Single-dose protection; contraindicated in pregnant sheep due to teratogenesis (fetal death, porencephaly) and risk of vector-mediated genetic reassortment.

• Inactivated Vaccines: Highly safe and suitable for pregnant animals, though requiring regular booster doses.

• TANUVAS Pentavalent Inactivated Vaccine (India): Incorporates Indian serotypes $1$, $2$, $10$, $16$, and $23$; administered as a $2\,\text{ml}$ subcutaneous dose between July and September prior to the Northeast monsoon.